Moxifloxacin + rifapentine for tuberculosis, lymph node

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2024: Trial registered, NCT06253715
  2. 15 Jan 2025: Trial started, NCT06253715

The trials

NCT06253715: Shortened Regimen for Drug-susceptible TB in Children

State
Under way
Phase
Phase 3
People
860 planned
Started
15 Jan 2025
Primary completion
30 Sep 2027
Arms
Regimen 2: Isoniazid (H), Rifapentine (P), Pyrazinamide (Z), Moxifloxacin (M)
Results
None posted
  1. 12 Feb 2024: Trial registered
  2. 15 Jan 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.